argenx SE (ARGX)
372.83
+4.23
(+1.15%)
USD |
NASDAQ |
Apr 26, 16:00
372.83
0.00 (0.00%)
After-Hours: 20:00
argenx Total Assets (Quarterly): 4.542B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.542B |
| June 30, 2023 | 3.194B |
| December 31, 2022 | 3.134B |
| June 30, 2022 | 3.249B |
| December 31, 2021 | 2.850B |
| June 30, 2021 | 3.213B |
| December 31, 2020 | 2.279B |
| June 30, 2020 | 2.275B |
| December 31, 2019 | 1.610B |
| June 30, 2019 | 1.147B |
| June 30, 2019 | 1.147B |
| December 31, 2018 | 661.70M |
| Date | Value |
|---|---|
| June 30, 2018 | 416.26M |
| June 30, 2018 | 416.26M |
| December 31, 2017 | 444.98M |
| June 30, 2017 | 212.19M |
| December 31, 2016 | 111.24M |
| June 30, 2016 | 130.51M |
| December 31, 2015 | 50.25M |
| June 30, 2015 | 61.15M |
| December 31, 2014 | 71.15M |
| June 30, 2014 | 38.00M |
| March 31, 2014 | 31.00M |
| December 31, 2013 | 34.54M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.147B
Minimum
Jun 2019
4.542B
Maximum
Dec 2023
2.604B
Average
2.850B
Median
Dec 2021
Total Assets (Quarterly) Benchmarks
| TC BioPharm (Holdings) PLC | 11.38M |
| Adaptimmune Therapeutics PLC | 282.62M |
| Merus NV | 455.49M |
| NuCana PLC | 35.43M |
| Biophytis SA | 13.22M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 444.95M |
| Shareholders Equity (Quarterly) | 4.098B |
| Current Ratio | 9.749 |